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Background and objectives: Previous studies have shown that individuals with low birth weight 2 
(LBW) or small for gestational age (SGA) have higher risk of kidney failure. The present study 3 
investigates birth related exposures and risk of chronic kidney disease and other kidney diagnoses.  4 
Design, setting, participant and measurements: The Medical Birth Registry of Norway has registered 5 
extensive medical data on all births in Norway since 1967.  The Norwegian Patient Registry has 6 
registered diagnostic codes for all admissions and outpatient visits to Norwegian hospitals since 7 
2008. Data from these registries were linked, and risk of chronic kidney disease (CKD) and other 8 
groups of kidney disease were analyzed using logistic regression statistics. LBW (<10th percentile), 9 
SGA (birth weight <10th percentile for gestational age) and preterm birth (less than 37 weeks) were 10 
analyzed as exposures.  11 
Results: A total of 2,663,010 individuals were included. After a mean follow-up of 26 years (max 50 12 
years), 4495 had been diagnosed with CKD and 12,818 with other groups of kidney disease. LBW was 13 
associated with an odds ratio (OR) for CKD of 1.72 (1.60-1.90), SGA with an OR of 1.79 (1.65-1.94) 14 
and preterm birth with an OR of 1.48 (1.33-1.66). Analyses using diagnosis of chronic kidney disease 15 
at stage 3, 4 or 5 as endpoint showed similar results. Results were similar for men and women. We 16 
further analyzed adjusted (aOR) for other groups of kidney disease, and found that LBW was 17 
associated with an aOR of 1.44 (1.33-1.56) for acute kidney disease, 1.24 (1.14-1.36) for 18 
glomerulonephritis, 1.35 (1.17-1.56) for cystic kidney disease and 1.15 (1.06-1.25) for kidney disease 19 
due to kidney or urinary tract malformations.  20 
Conclusions: LBW, SGA and preterm birth are associated with higher risk of CKD in the first 50 years 21 
of life. Risk of other groups of kidney disease was less pronounced. 22 
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 In the 1980s, Brenner et al proposed that intrauterine growth restriction cause  a low 2 
nephron number, which could predispose to hypertension and kidney disease through mechanisms 3 
of increased single-nephron glomerular filtration, compensatory nephron hypertrophy and 4 
decreased functional reserve 1. Approximately 60% of the nephrons develop during the third 5 
trimester of pregnancy, and kidney development ends between 35 and 36 weeks of gestation2. Thus, 6 
preterm birth or impaired intrauterine growth may significantly impact the formation of nephrons 7 
and reduce nephron number3.  8 
Previous cohort studies have linked low birth weight and risk of severe kidney failure4-7 and 9 
studies have also linked low birth weight with lower estimated glomerular filtration rate or urinary 10 
albumin2,8-10. This is believed to be related to lower numbers of nephrons and glomerular 11 
hypertrophy that has been shown in low birth weight individuals 3,11,12. Recent studies have 12 
emphasized the interplay between markers of intrauterine growth such as LBW, SGA and 13 
prematurity and risk of kidney disease in adult life 2,13-15.  An important paper from the Low Birth 14 
Weight and Nephron Number Working Group argued that individuals with low birth weight should 15 
undergo screening and follow-up to detect kidney disease or risk factors for kidney disease at an 16 
early age16.  Early detection of individuals at risk of kidney disease, as well as early referral  to kidney  17 
units may  slow disease  progression, improve survival in patients with CKD and reduce total  18 
treatment cost 17.   19 
There is a need for better data on the association between different markers of intrauterine 20 
growth restriction and risk of clinical kidney disease at an earlier stage than severe kidney failure. In 21 
this retrospective, register based nationwide cohort study we linked data from Norwegian registries 22 
to explore the association between birth related variables such as low birth weight, low birth weight 23 
for gestational age, preterm birth and risk of different groups of kidney disease during the first 50 24 
years of life. 25 
  26 
4 
 
Materials and methods 1 
Data sources 2 
 Since 1967, the Medical Birth Registry of Norway (MBR) has registered extensive medical 3 
data on all births in Norway. The Norwegian Patient registry (NPR) has registered ICD-10 diagnostic 4 
codes for all admissions and outpatient visits to Norwegian hospitals since 2008; in Norway most 5 
specialist care in the field of nephrology is hospital-based and the data is therefore almost complete 6 
for specialist care. ICD-10 codes were registered by the treating physicians. For the present study we 7 
obtained data from NPR for the period 2008-2016. Date of death was available from the Norwegian 8 
Population Registry. We linked these registries using the national identification number.  9 
All individuals born in Norway between 1967 and 2015 were included. We excluded twins, 10 
triplets, quadruples (N= 76,429), individuals who died before age 1 year (N=17,146) and individuals 11 
who died before 2008 (N=16,417). Individuals who officially had emigrated from Norway were also 12 
excluded (N=80,332). 13 
Birth related variables 14 
LBW was defined as birth weight less than the 10th percentile for gender (2940 g for male, 15 
2850 g for female). From 1967 through 1998, gestational age was based on the last menstrual period 16 
and from 1999 onward on routine ultrasonographic examination in gestational week 17 through 20. 17 
Based on birth weight, gestational age and gender, a z-score of birth weight for gestational age has 18 
been calculated for all single births. We defined SGA as birth weight less than the 10th percentile for 19 
gestational age and gender. Preterm birth was defined as birth before 37 weeks of pregnancy. Low 20 
birth weight less than 2500 grams was also analyzed as an exposure variable.  21 
Maternal preeclampsia has been diagnosed according to the ACOG criteria 18,19. For the 22 
present study, pre-gestational maternal disease was defined as a diagnosis of maternal diabetes 23 
mellitus, kidney disease, rheumatic disease or essential hypertension before pregnancy. Maternal 24 
marital status was dichotomized as either single or not single. Congenital malformations in the 25 
newborns had been recorded as present if any malformation had been observed before discharge 26 
from hospital; in the statistical analyses, a dichotomous variable was used.  27 
Outcome variables  28 
The data file from NPR included ICD-10 codes for each episode (admission or outpatient visit) 29 
with a kidney disease diagnosis (N01-N09, N17-N19, N25-29 or Q60-64). Of the 17,313 individuals 30 
with at least one episode with kidney disease, 6494 had one episode, 2377 had two episodes, 1465 31 
had three episodes, 3934 had 4-9 episodes, 1751 had 10-19 episodes and 1295 had 20 episodes or 32 
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more (maximum 1370 episodes). Patients were diagnosed with different combinations and 1 
sequences of ICD10 codes.  In the present study we analyze whether or not a diagnosis or group of 2 
diagnoses had been recorded at least one time.  3 
The main outcome was defined as having been diagnosed with chronic kidney disease (ICD10 4 
code N18) in at least one of the episodes (admissions or outpatient visits). Both main diagnoses and 5 
secondary diagnoses were included.  6 
The secondary outcomes were having been diagnosed with different groups of kidney 7 
disease: acute kidney disease (N17), glomerular disease (N00-N09), cystic kidney disease (Q61) or 8 
kidney or urinary tract malformations (Q60, Q62-Q64). We also analyzed the secondary outcome of 9 
having been diagnosed with stage 3, 4 or 5 of kidney disease (these diagnoses were used in the 10 
registry for the time period 2010-2016).  11 
Statistical analysis 12 
 In the statistical analyses, main and secondary outcomes were analyzed as either present or 13 
absent. Main exposure variables were LBW, SGA and preterm birth. Low birth weight < 2.5 kg, 14 
combinations of the main exposure variables and different cut-offs for birth weight and birth weight 15 
for gestational age were also analyzed. For the included participants, 0.1% had missing data on birth 16 
weight and 4.3% for gestational age and z-score. These participants were excluded from the 17 
respective analyses. Characteristics of different groups were compared using t-tests for continuous 18 
variables and Pearson’s chi-square test for categorical variables. In the main analyses, logistic 19 
regression statistics was used to investigate the associations between exposure variables and the 20 
outcome of interest. In adjusted analyses we adjusted for gender, pre-gestational maternal disease, 21 
maternal marital status and congenital malformations recorded shortly after birth. In analyses 22 
focusing on the associations in adult age, only individuals born before 1990 were included. 23 
 In secondary analyses, we used left truncated Cox regression statistics to complement the 24 
logistic regression statistics. Exposure and outcome variables were the same as in the logistic 25 
regression analyses. Time until endpoint was age at first occurrence, time until right censoring was 26 
age at death or end of 2016. As we did not have data on outcomes until 2008, analyses were left- 27 
truncated for the time period until 2008.  28 
 A two–tailed probability value of < 0.05 was considered significant. All analyses were 29 
performed using STATA version 15.1 (Stata Corp, College Station, Texas). 30 
 31 




 A total of 2,663,010 individuals were included in the present study, 51.3% were male and 2 
mean birth year was 1991 (range 1967-2015). In the period 2008-2016, 17,313 individuals had been 3 
diagnosed with a kidney disease, 4495 with chronic kidney disease (CKD), 4659 with acute kidney 4 
disease, 4672 with glomerular disease, 1479 with cystic kidney disease and 5085 with congenital 5 
malformations of the kidney or urinary tract. Figure 1 shows how the different groups of kidney 6 
disease combined for each patient. Patients with CKD most commonly had other groups of kidney 7 
disease. Table 1 shows birth related characteristics for the total cohort and for the different groups 8 
of kidney disease. Mean age at diagnosis differed between groups, kidney or urinary tract 9 
malformations were diagnosed in younger patients and chronic kidney disease in higher age. 10 
Participants who were diagnosed with CKD had more often LBW and SGA than participants who were 11 
diagnosed with other diseases. The same was observed for combinations of diagnoses, ie. 14.1% of 12 
participants with acute kidney disease but not CKD had LBW, 16.1% of participants with CKD but not 13 
acute kidney disease had LBW and 16.5% of participants with CKD and acute kidney disease had LBW.  14 
 Compared with individuals with birth weight above the 10th percentile, LBW was associated 15 
with a higher odds ratio (OR) of 1.72 (1.60-1.90) for development of CKD (Table 2). Corresponding 16 
ORs for individuals with SGA was 1.80 (1.75-1.94), for preterm birth 1.50 (1.33-1.66), for birth weight 17 
< 2.5 kg 1.85 (1.62-2.10) and for maternal preeclampsia OR was 1.11 (0.94-1.31). There were no clear 18 
gender differences, except an impression that women seemed to be less affected by preterm birth 19 
and more by maternal preeclampsia (Table 2). The adjusted analyses were repeated in the cohort 20 
born before 1990 to focus on the adult population, with very similar results. These analyses 21 
described in Table 2 were repeated using cox regression statistics, with virtually identical results. As 22 
can be seen from Figure 2, cumulative risk of CKD was higher for both LBW and SGA. We further 23 
analyzed odds ratio of being diagnosed with chronic kidney disease stage 3, 4 or 5. In these analyses, 24 
LBW was associated with an OR of 1.80 (1.60-2.05) for CKD stage 3, 1.84 (1.56-2.18) for CKD stage 4 25 
and 1.88 (1.58-2.24) for CKD stage 5 (Supplemental Table 1). Corresponding ORs for SGA was 1.89, 26 
2.04 and 1.78, for preterm birth 1.65, 1.59 and 1.44 and for birth weight <2.5 kg 2.09, 1.82 and 1.93.  27 
 In Figure 3 we investigated possible dose-response relationships for low birth weight and low 28 
birth weight for gestational age. In these analyses we categorized birth weight and birth weight for 29 
gestational age according to gender specific percentiles, the following groups were analyzed: below 30 
5th percentile, 5-10th, 10-20th, 20-80th (reference), 80-90th, 90-95th and above 95th percentile cut-offs. 31 
Dose-response relationships were observed for both low birth weight and birth weight for 32 
gestational age, with higher risks for lower birth weights. Higher risk was seen below the 10th 33 
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percentile for both LBW and SGA, but significant slightly higher ORs were seen for the 10-20th 1 
percentile groups for men.  2 
 To further analyze the effects of LBW, SGA and preterm birth, we investigated how 3 
combinations of these exposures associated with risk of CKD. As compared to having none of the 4 
exposures, individuals with one exposure had a significantly higher risk and the effect seemed similar 5 
for the three exposures (Table 3). Individuals with two exposures had a higher risk than individuals 6 
with one exposure, especially individuals with LBW and SGA, and individuals with three exposures 7 
had an even higher risk (Figure 4). These analyses were also repeated in the cohort born before 1990 8 
to focus on the adult population, showing nearly identical results, except that the OR for individuals 9 
with only one exposure was attenuated and only significant for LBW or SGA. Analyses described in 10 
Table 3 were repeated using cox regression with virtually identical results. In order to analyze a 11 
possible contribution from preeclampsia, we chose to stratify the analyses in Table 3. The results 12 
showed that preeclampsia did not significantly affect the contribution of these other exposures 13 
(results not shown).  14 
 In the above analyses we have used CKD as the main outcome. In Table 4 we presented 15 
results for other groups of kidney disease, and showed that birth related risk factors were most 16 
strongly associated with the CKD group. Unadjusted and adjusted analyses showed similar results, 17 
only the adjusted results are shown in the table. Supplemental Table 2 shows the results for the adult 18 
cohort born before 1990.  19 
 20 
 21 




The present study showed that intrauterine growth restriction was associated with a 60-70% 2 
higher risk of being diagnosed with chronic kidney disease (CKD) during the first 50 years of life. The 3 
associations were similar for CKD stage 3, 4 and 5, similar for men and women and mostly the same 4 
in the adult cohort. Different markers of intrauterine growth restriction were tested and LBW and 5 
SGA yielded similar results that seemed to be stronger than for preterm birth. There was also 6 
significantly higher risks for other groups of kidney disease, but not as strongly as for CKD. Given the 7 
high population prevalence of CKD20-23, and the high comorbidity and mortality in CKD24 , our results 8 
may have public health importance.  9 
 The main finding in our study is that it provides evidence that subjects born with LBW and 10 
SGA not only have higher risk for development of kidney failure4,7 but also for the much more 11 
prevalent CKD. Global prevalence of CKD has been shown to be about 12%, with stage 3 prevalence 12 
7.6%, stage 4 prevalence 0.4% and stage 5 prevalence 0.1%20. In the present study, individuals born 13 
with LBW or SGA had an unadjusted OR of about 1.72 for being diagnosed with CKD. In analyses of 14 
birth weight percentiles, we observed higher risks for lower birth weights as well as trends towards 15 
lower risks for birth weights above normal. In analyses of combinations of birth related exposures, 16 
having more exposures were associated with higher risks and LBW and SGA seemed more important 17 
than preterm birth. Interestingly, we could not find evidence on gender differences, in difference to 18 
other studies 7,9,13,25 19 
In the present study, cumulative proportion of CKD at 50 years of age was 1.7% in individuals with 20 
LBW as compared to 1.0% in those without LBW. The real prevalence of CKD might however be much 21 
higher, as there is a well-known under-ascertainment of CKD in administrative databases as these 22 
rely on the patient having been referred to specialist care for evaluation26,27. A meta-analysis of CKD 23 
prevalence did for example show that prevalence of stage 3-5 in population screening is about 12% 24 
at 50 years of age20. It could be expected that the higher relative risk would be the same irrespective 25 
of the higher prevalence with increasing age, the absolute importance of LBW would thus be likely to 26 
be higher20,28. Review papers have argued for routine follow-up to detect early kidney disease in all 27 
individuals with LBW, SGA or preterm birth 2,16 and our study strengthen these arguments. Studies of 28 
the effect of screening in adults and older adults seem warranted to assess cost vs benefit.  29 
Our study confirms previous Norwegian studies that LBW, SGA and preterm birth are 30 
associated with higher risk for kidney disease in adult age4,7. A recent study showed that combination 31 
of these exposures are associated with a further higher risk of CKD, and that individuals with only one 32 
exposure did not have a higher risk29. In contrast, the present study found that also individuals with 33 
only one exposure had a higher risk, and the contribution from preterm birth seemed to be weaker. 34 
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The importance of SGA has been documented in the present study and several previous studies 4,7,30.  1 
A Swedish study showed an important higher risk associated with preterm birth, an effect that was of 2 
the same magnitude as for LBW and SGA in our study31.  It is however difficult to directly compare 3 
these studies as there are considerable overlap between the exposures. The Swedish study did not 4 
include data on birth weight and it also showed a much weaker effect for preterm birth after 20 years 5 
of age as compared to our study. Our study showed clear associations between LBW and SGA and risk 6 
of CKD also in adult age as well as that the findings of the number of exposures also may be important.  7 
Several studies have  described the association between LBW and different indicators of 8 
kidney disease such as albuminuria, low eGFR, or kidney failure13. LBW has also been linked to 9 
moderately higher blood pressure 7, impaired glucose homeostasis32, microalbuminuria, and 10 
endothelial dysfunction. In our study we found that LBW also was associated with higher risk of acute 11 
kidney disease, glomerular disease, cystic kidney disease and kidney and urinary tract malformations, 12 
although these risks were lower than for CKD. As kidney or urinary tract malformations, as well as 13 
cystic kidney disease, could cause intrauterine growth restriction, this part of our findings could be 14 
expected. In a previous paper we did in fact show that LBW was especially strongly associated with 15 
risk of congenital and hereditary kidney disease before age of 15 years 4. In the present study we did 16 
however show a significantly higher risk also in the adult cohort born before 1990 (supplemental 17 
Table 2). Unadjusted analyses, adjusted analyses and analyses for the adult cohort showed very 18 
similar results and we thus believe that the potential for residual confounding is of smaller 19 
significance. The higher risk of glomerulonephritis could also be expected based on previous studies 20 
that has suggested that autoimmune disease could be caused by early life perturbations33, but the 21 
higher risk of being diagnosed with glomerulonephritis has to our knowledge previously not been 22 
demonstrated in a population based study.  23 
The major strengths of our study are the opportunity to use the national registries to include 24 
a large number of participants with prospective registration of birth related variables, the long 25 
follow-up period of 50 years and the stability of the Norwegian population with little or no 26 
emigration during follow-up. About 2% of the included population had been officially recorded as 27 
emigrated and were excluded from the study, but a cross-check by Statistics Norway showed that 28 
another 2.% currently were living abroad. Further strengths are that most kidney disease diagnoses 29 
are assessed and treated in hospitals, and that we included both main diagnoses and secondary 30 
diagnoses in the data. The study population is mostly Caucasian, which is both a strength and a 31 
weakness.  On the downside, results might be different in other populations. But the upside is that 32 
the Norwegian population is quite homogeneous with equal access to specialist health care, this 33 
could allow for better internal comparability and reduce potential confounding such as low socio-34 
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economic status, educational level and ethnic origin. We did not have access to these data in our 1 
study, but we were able to adjust for single vs non-single mother which is a socio-economic marker.  2 
The main weakness is that we could not record endpoints until 2008. Our data thus reflects 3 
prevalence of CKD during the years 2008-2015. Given the wide age range of 0-50 years we believe 4 
that our data also could reflect incidence of CKD. Based on these reflections we decided to perform 5 
the main statistics as logistic regression statistics, but also performed left-truncated survival statistics 6 
to investigate the age-associated risk of CKD. These two approaches showed mainly identical results. 7 
As discussed above, there is probably an under-reporting of CKD in this administrative 8 
databases26,27,34. An important weakness is also that chronic kidney disease documented in patient 9 
journals by albuminuria or lower estimated glomerular filtration rate will not be coded in the 10 
diagnostic databases if not relevant for the patient care that was given. The treating physicians 11 
decide which ICD-10 diagnostic codes to use, and although we believe that these mostly are correct, 12 
diagnostic codes of kidney disease have to our knowledge not been validated in Norway. Other 13 
limitations include lack of data on other important risk factors such as diabetes, hypertension, 14 
smoking, dyslipidemia and other exposures of kidney disease.   15 
 16 
 Conclusions 17 
We have shown that intrauterine growth restriction is associated with a 60-70% higher risk of 18 
being diagnosed with CKD during the first 50 years of age. Findings were similar for men and women, 19 
and were similar for LBW and SGA. Future studies will need to address whether screening of subjects 20 
with intrauterine growth restriction could have a beneficial cost-benefit ratio and also how 21 
intrauterine growth restriction modifies the effect of other known kidney disease exposures. Starting 22 
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Table 1. Characteristics of participants in the Norwegian Patient Registry 
Characteristic Total Diagnostic groups Any kidney 










N 2,663,010 4495 4659 4672 1479 5085 17,313 
% male 51% 61%c 62.1%c 52.5% 49.2% 57.3%c 57.3%c 
Birth year  1991±14 1979±11c 1980±11c 1987±14c 1991±16 2003±11c 1989±15 c 
Duration follow-up*(years) 26±14 33.1±11.0  32.6±11.5 24.9±13.5 20.7±15.9 8.5±10.9 23.1±15.6  
% maternal marital status single 10% 11.6%c 13.1%c 10.5%a 9.7% 7.8%c 10.7%c 
% LBW (<10th percentile) 10% 16.1%c 14.6%c 12.5%c 14.8%c 13.4%c 13.7%c 
% SGA (<10th percentile) 10% 16.5%c 15.3%c 12.2%c 13.5%c 10.6% 13.1%c 
% preterm birth (<37 weeks) 4.6% 6.6%c 5.9%c 5.3%a 7.9%c 7.0%c 6.1%c 
% birth weight <2.5 kg 3.2% 5.7%c 4.9%c 4.5%c 5.2%c 4.9%c 4.9%c 
% 1 risk factor** 6.9% 9.5%c 8.8%c 7.5%a 9.3%c 6.9% 7.9%c 
% 2 risk factor** 8.0% 12.7%c 12.2%c 9.8%c 11.1%c 11.1%c 10.8%c 
% 3 risk factor** 0.64% 1.5%c 0.94%c 1.0%c 1.5%c 1.3%c 1.1%c 
% congenital malformations 3.0% 6.6%c 4.6%c 3.9%c 25%c 29.4%c 12.6%c 
% Apgar 5 minutes < 7 0.96% 2.5%c 3.0%c 0.96% 2.6%c 1.9c 2.0%c 
% Maternal disease before 
pregnancy*** 
2.4% 3.3%c 2.8% 3.1%b 7.8%c 4.2%c 3.6%c 
% Maternal preeclampsia 2.9% 3.2%c 2.6% 2.9% 4.5%c 3.0% 3.1%c 
ap<0.05, bp<0.01, cp<0.001 as compared to total 
*Duration of follow-up until diagnosis or end of 2016. 
**LBW (low birth weight), SGA (small for gestational age) or preterm birth. 





Table 2. Associations of low birth weight, small for gestational age, preterm birth, or maternal preeclampsia with subsequent diagnosis of chronic kidney 
disease 
Exposure  Unadjusted  Adjusted  Adjusted 
  Total cohort  Men Women  Cohort born before 1990 
  N 
CKD 
OR (95% CI) p  N 
CKD 
OR (95% CI)* p N 
CKD 
OR (95% CI)* p  OR (95% CI)* p 
Birth weight 
<10th percentile - 
LBW 
No 3759 1.0 (ref)   2304 1.0 (ref)  1455 1.0 (ref)   1.0 (ref)  
Yes 724 1.72(1.60-1.90 <0.001  427 1.56 (1.411.73) <0.001 297 1.72(1.51-2.00) <0.001  1.58 (1.45-1.73) <0.001 
               
Z-score <10th 
percentile - SGA 
No 3564 1.0 (ref)   2174 1.0 (ref)  1390 1.0 (ref)   1.0 (ref)  
Yes 708 1.79 (1.65-1.94) <0.001  430 1.52 (1.37-1.70) <0.001 278 1.51 (1.33-1.72) <0.001  1.51 (1.40-1.63) <0.001 
               
Preterm birth No 4196 1.0 (ref)   2541 1.0 (ref)  1655 1.0 (ref)   1.0 (ref)  
Yes 299 1.48 (1.33-1.66) <0.001  198 1.55 (1.34-1.80) <0.001 101 1.40 (1.14-1.71) 0.001  1.35 (1.17-1.55) <0.001 
               
Birth weight  
< 2.5 kg 
No 4235 1.0 (ref)   2587 1.0 (ref)  1648 1.0 (ref)   1.0 (ref)  
Yes 260 1.85 (1.62-2.10) <0.001  152 1.87 (1.58-2.20) <0.001 108 1.80 (1.49-2.2) <0.001  1.79 (1.55-2.07) <0.001 
               
Maternal 
preeclampsia 
No   4352 1.0 (ref)    1.0 (ref)   1.0 (ref)   1.0 (ref)  
Yes 143 1.11 (0.94-1.31) 0.2   1.18 (0.94-1.50) 0.15  1.44 (1.12-1.9) 0.005  1.26 (1.04-1.33) 0.018 
*Adjusted for gender, maternal disease (defines as maternal diabetes mellitus, kidney disease, rheumatic disease or essential hypertension diagnosed 






Table 3. Associations for subsequent diagnosis of chronic kidney disease according to whether the individuals had low birth weight, were small for 
gestational age, or were born preterm . Separate analyses for total cohort and the cohort born before 1990. 
Exposure Total cohort (born 1967-2015) 
 
Cohort born before 1990 






Total N N CKD Adjusted OR * 
(95% CI) 
p-value 
Term, Not LBW or SGA 2,147,243 3248 1.0 (ref) 1.0 (ref)   955,093 2681 1.0 (ref)  
Term, not LBW, SGA 99,862 240 1.59 (1.39-1.81) 1.57 (1.38-1.79) <0.001 
 
56,462 210 1.32 (1.14-1.52) <0.001 
Term, LBW, not SGA 33,877 74 1.44 (1.15-1.82) 1.41 (1.12-1.78) 0.002 
 
13,199 53 1.41 (1.07-1.85) 0.01 
Preterm, not LBW or SGA 40,540 89 1.45 (1.17 -1.79) 1.40 (1.13-1.72) 0.002 
 
19,327 62 1.11 (0.86-1.43) 0.4 
Preterm, not LBW, SGA No data No data 
 
   No data    
Term, LBW and SGA 137,891 402 1.92 (1.74-2.14) 1.88 (1.70-2.10) <0.001 
 
72,175 345 1.70 (1.52-1.90) <0.001 
Preterm, LBW, not SGA 65,013 141 1.43 (1.21-1.70) 1.36 (1.15-1.61) <0.001 
 
25,427 103 1.40 (1.15-1.71) 0.001 
Preterm, LBW and SGA 16,299 66 2.67 (2.10 -3.42) 2.50 (2.00-3.18) <0.001 
 
6,174 47 2.63 (1.96-3.53) <0.001 
Number of risk factors**           
0 2,147,243 3248 1.0 (ref) 1.0 (ref)   995,093 2681 1.0 (ref)  
1 174,279 403 1. 52(1.37-1.69) 1.50(1.35-1.66) <0.001 
 
88,988 325 1.28 (1.14-1.44) <0.001 
2 202,904 543 1.76 (1.61-1.93) 1.72(1.57-1.89) <0.001 
 
97,602 448 1.62 (1.47-1.79) <0.001 
3 16,299 66 2.67 (2.09-3.41) 2.49(1.95-3.19) <0.001 
 
6,174 47 2.63 (1.96-3.53) <0.001 
*Adjusted for gender, maternal disease (defines as maternal diabetes mellitus, kidney disease, rheumatic disease or essential hypertension diagnosed 
before pregnancy), maternal marital status and malformations in the newborn. 




Table 4. Associations of low birth weight, small for gestational age or preterm birth with diverse forms of  kidney disease  
 
Exposure  Chronic kidney disease Acute kidney injury Glomerulonephritis Hereditary kidney 
disease 
Malformations of the 
kidney or urinary tract 
  N aOR (95% CI)* N aOR (95% CI)* N aOR (95% CI)* N aOR (95% CI)* N aOR (95% CI)* 
Birth weight <10th 
percentile – LBW  
No 3759 1.0 (ref) 3971 1.0 (ref) 4086 1.0 (ref) 1258 1.0 (ref) 4394  
Yes 724 1.62 (1.50-1.76) 678 1.44 (1.33-1.56) 581 1.24 (1.14-1.36) 219 1.35 (1.17-1.56) 679 1.15 (1.06-1.25) 
Z-score <10th 
percentile - SGA  
No 3564 1.0 (ref) 3730 1.0 (ref) 3900 1.0 (ref) 1240 1.0 (ref) 4465  
Yes 708 1.52 (1.40-1.65) 675 1.60 (1.49-1.73) 543 1.18 (1.070-
1.30) 
194 1.31 (1.12-1.52) 531 1.13 (1.03-1.23) 
            
Preterm birth No 4196 1.0 (ref) 4385 1.0 (ref) 4423 1.0 (ref) 1362 1.0 (ref) 4727  
Yes 299 1.49 (1.33-1.68) 274 1.30 (1.15-1.47) 249 1.17 (1.03-1.33) 117 1.43 (1.18-1.74) 358 1.08 (0.97-1.21) 
            
Birth weight  
< 2.5 kg 
No 4235 1.0 (ref) 4429 1.0 (ref) 4464 1.0 (ref) 1402 1.0 (ref) 4835  
Yes 260 1.84 (1.62-2.08) 230 1.56 (1.36-1.79) 208 1.40 (1.21-1.60) 77 1.30 (1.03-1.63) 250 1.07 (0.94-1.22) 
*Adjusted for gender, maternal disease (defines as maternal diabetes mellitus, kidney disease, rheumatic disease or essential hypertension diagnosed 





Supplemental table 1.  Associations of low birth weight, small for gestational age or preterm birth with chronic kidney disease stage 3, 4 or 5 
Exposure  CKD stage 3  CKD Stage 4 CKD stage 5 
  N OR (95% CI)  N OR(95% CI) N OR (95% CI) 
Birth weight 
<10th percentile 
No 1501 1.0 (ref)  809 1.0 (ref) 722 1.0 (ref) 
Yes 304 1.80 (1.60-2.05)  167 1.84 (1.56-2.18) 152 1.88 (1.58-2.24) 
         
Z-score <10th 
percentile 
No 1415 1.0 (ref)  763 1.0 (ref) 694 1.0 (ref) 
Yes 297 1.89 (1.67-2.14)  173 2.04 (1.73-2.41) 137 1.78 (1.48-2.13) 
         
Preterm birth No 1676 1.0 (ref)  913 1.0 (ref) 823 1.0 (ref) 
Yes 133 1.65 (1.38-1.97)  70 1.59 (1.25-2.03) 57 1.44 (1.10-1.88) 
         
Birth weight  
< 2.5 kg 
No 1692 1.0 (ref)  927 1.0 (ref) 827 1.0 (ref) 






Supplemental Table 2. Associations of low birth weight, small for gestational age or preterm birth with diverse forms of  kidney disease. Analyses for 
cohort born before 1990. 
Exposure  Chronic kidney disease Acute kidney injury Glomerulonephritis Hereditary kidney 
disease 
Malformations of the 
kidney or urinary tract 
  N aOR (95% CI)* N aOR (95% CI)* N aOR (95% CI)* N aOR (95% CI)* N aOR (95% CI)* 
Birth weight <10th 
percentile – LBW  
No 3095 1.0 (ref) 3085 1.0(ref) 2362 1.0(ref) 631 1.0(ref) 560 1.0(ref) 
Yes 582 1.58 (1.45-1.73) 524 1.43(1.30-1.57) 341 1.23(1.10-1.38) 93 1.23 (0.99-1.54) 78 1.17(0.92-1.50) 
Z-score <10th 
percentile - SGA  
No 2907 1.0 (ref) 2879 1.0(ref) 2204 1.0(ref) 594 1.0(ref) 524 1.0(ref) 
Yes 602 1.51 (1.40-1.65) 556 1.41(1.30-1.55) 361 1.22(1.10-1.36) 108 1.33 (1.10-1.64) 83 1.16(0.92-1.50) 
            
Preterm birth No 3471 1.0(ref) 3418 1.0(ref) 2580 1.0(ref) 693 1.0(ref) 614 1.0(ref) 
Yes 241 1.38(1.17-1.55) 197 1.25(1.10-1.45) 125 1.10(0.90-1.30) 38 1.22(0.88-1.70) 26 0.96(0.66-1.42) 
            
Birth weight  
< 2.5 kg 
No 3483 1.0(ref) 3446 1.0(ref) 2594 1.0(ref) 705 1.0(ref) 613 1.0(ref) 
Yes 202 1.80(1.55-2.07) 169 1.51(1.30-1.78) 111 1.32(1.09-1.60) 26 1.15(0.75-1.65) 27 1.28(0.87-2.00) 
*Adjusted for gender, maternal disease (defines as maternal diabetes mellitus, kidney disease, rheumatic disease or essential hypertension diagnosed 




Figures and legends 
 
Figure 1. Number of individuals diagnosed with combinations of different groups of kidney disease.  
Patients with CKD most commonly had other groups of kidney disease. In patients with CKD, 14% 
also had acute kidney disease, 25% had glomerular disease, 6% had cystic kidney disease, 3% had 
kidney or urinary tract malformations, 9% had several groups of kidney disease and 44% were coded 







Figure 2. Cumulative incidence (%) of CKD according to LBW and SGA. Cumulative risk of CKD was 
higher for both LBW and SGA, and the graphs separate most strongly in adult age.  Cumulative 
proportion with CKD at 50 years of age was 1.0% in individuals without LBW and 1.7% in individuals 





Figure 3. Odds ratio for CKD according to different percentiles for birth weight (top) and birth weight 
for gestational age (bottom). Dose-response relationships were observed for both low birth weight 
and birth weight for gestational age, with higher risks for lower birth weights. Higher risk was seen 
below the 10th percentile for both LBW and SGA, but significant slightly higher ORs were seen for the 





Figure 4. Cumulative Incidence (%) of CKD according to number of birth related risk factors (birth 
weight <10th percentile, birth weight for gestational age <10th percentile and preterm birth).  
Compared to having none of the exposures, individuals with one exposure had a significantly higher 
risk. Individuals with two exposures had a higher risk than individuals with one exposure and 
individuals with three exposures had an even higher risk. 
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